Pharmaceutical News and Articles

$250B of U.S. Health Costs Could Be Tied to Exposure to Chemicals in Plastics

Plastics exposure contributes substantially to disease costs in the United States, according to a study published online Jan. 11 in the Journal of the Endocrine

1975 to 2019 Saw 58 Percent Decrease in Breast Cancer Mortality

In the United States, breast cancer screening and treatment were associated with a 58 percent reduction in breast cancer mortality in 2019 compared with 1975, a

'Default' Orders for Palliative Care Speed Relief for Hospital Patients in Pain

but it is always there if they don t. After instituting this system across 11 hospitals, palliative care consultation rates rose from 16.6 percent of cases to 4

Stressed Teens at Risk of Heart Trouble Years Later

Stressed-out teens are likely to have more heart health risk factors in adulthood, a new study says.Teens with elevated stress levels tended to have high blood

Walking, Biking to Work Lowers Inflammation That Could Trigger Disease

didn t significantly alter active commuting s effect on inflammation, the investigators noted.It did seem that at least 45 minutes of active commuting was neede

FDA Clears Sickle Cell Drug to Treat Another Blood Disorder

Casgevy, a groundbreaking treatment that was approved to treat sickle cell disease in December, was given the U.S. Food and Drug Administration s blessing on Tu

American Air Is Getting Cleaner, But Benefits Aren't Reaching All

An American s income and ethnicity could play a role in how clean the air is that they breathe, a new study finds.Air pollution emissions have fallen more in we

Vertex Announces US FDA Approval of Casgevy (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia

Cannabis Does Not Impact Nonmedical Opioid Use in Opioid Use Disorder

For patients receiving pharmacotherapies for opioid use disorder (OUD), cannabis use is not associated with nonmedical opioid use, according to a systematic rev

Liraglutide Exerts Weight Loss-Independent, GLP-1R-Dependent Effects

Use of the glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide exerts weight loss-independent, GLP-1R-dependent effects on insulin sensitivity, accord